StockDriftsStockDriftsTop 4 Ah Equity Partners Bio Ii, L.l.c. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EQRX | EQRx, Inc. | 60.15% | 17.44M | $86K | new | — | 2022-09-30 | |
| NAUT | Nautilus Biotechnology, Inc. | 24.08% | 16.30M | $35K | new | — | 2022-09-30 | |
| ERAS | Erasca, Inc. | 13.59% | 2.50M | $20K | new | — | 2022-09-30 | |
| NVTAQ | InVitae Corporation | 2.19% | 1.28M | $3K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Ah Equity Partners Bio Ii, L.l.c. reports $143.51K in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are EQRX (60.1%), NAUT (24.1%) and ERAS (13.6%). Figures reflect the Q3 2022 filing.
Sign up free to track Ah Equity Partners Bio Ii, L.l.c., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ah Equity Partners Bio Ii, L.l.c.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1725722). View Ah Equity Partners Bio Ii, L.l.c.’s 13F filings on SEC